NEOG Competitors & Alternatives
Compare Neogen Corp with similar stocks in the same industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
NEOG
Main Stock$10.25
Tradestie Score
59
Market Cap
$1.26B
Revenue Growth
0.0%
Analyst Upside
+13.8%
Top Competitors
19 stocks in IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IDXX
Idexx Laboratories Inc
|
$639.60
|
$49.61B | 53.8 | 40 | Compare |
|
LNTH
Lantheus Holdings, Inc
|
$66.50
|
$3.51B | 27.7 | 57 | Compare |
|
QDEL
QuidelOrtho Corporation Common Stock
|
$27.65
|
$2.12B | - | 54 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$13.06
|
$2.01B | - | 57 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$24.66
|
$1.68B | - | 48 | Compare |
|
NNNN
Anbio Biotechnology Class A Ordinary Shares
|
$24.66
|
$1.53B | 365.2 | 41 | Compare |
|
MYGN
Myriad Genetics Inc
|
$5.47
|
$719.23M | - | 49 | Compare |
|
TKNO
Alpha Teknova, Inc. Common Stock
|
$2.37
|
$340.89M | - | 50 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$4.30
|
$158.43M | - | 41 | Compare |
|
IMDX
Insight Molecular Diagnostics Inc. Common Stock
|
$6.86
|
$94.16M | - | 53 | Compare |
More NEOG Analysis
Data updated: Feb 03, 2026 | Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES (SIC 2835)
19 stocks in this industry